Oxygenta Pharmaceutical Limited (BOM:524636)
India flag India · Delayed Price · Currency is INR
52.11
+1.20 (2.36%)
At close: Jul 27, 2026

Oxygenta Pharmaceutical Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-21.490.020.020.180.72
Short-Term Investments
----0.890.84
Cash & Short-Term Investments
21.4921.490.020.021.061.56
Cash Growth
1664.37%126311.76%0%-98.40%-31.78%-65.02%
Accounts Receivable
-100.2850.9873.61101.615.76
Other Receivables
--44.9722.7--
Receivables
-100.2895.9596.31101.615.76
Inventory
-294.21205.13137.17117.0572.83
Prepaid Expenses
--0.830.40.240.11
Other Current Assets
-98.327.57.1730.115.38
Total Current Assets
-514.3309.43241.06250.0695.64
Property, Plant & Equipment
-475.99398.63293.58279.13203.2
Long-Term Investments
-4.740.490.490.490.49
Long-Term Accounts Receivable
-17.6910.83-3.973.68
Long-Term Deferred Tax Assets
-174.07108.0187.33--
Other Long-Term Assets
-10.026.815.264.794.55
Total Assets
-1,197834.2631.92542.65311.76

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-487.69297.94228.87237.864.59
Accrued Expenses
--18.7519.1333.785.23
Short-Term Debt
--399.4174.6349.7110.86
Current Portion of Long-Term Debt
-342.817.697.697.7-
Other Current Liabilities
-30.47134.686.62--
Total Current Liabilities
-860.97858.47336.95328.9880.68
Long-Term Debt
-752.86215.22490.02622.53510.43
Pension & Post-Retirement Benefits
--8.254.84.082.92
Long-Term Deferred Tax Liabilities
----16.5914.61
Other Long-Term Liabilities
-9.842.51.3832.4749.41
Total Liabilities
-1,6241,084833.151,005658.05

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-369.84369.84334.84142.01142.01
Additional Paid-In Capital
--115.9196.41--
Retained Earnings
---735.63-638.81-604.01-488.3
Comprehensive Income & Other
--796.7-0.366.34--
Shareholders' Equity
-426.87-426.87-250.25-201.22-462-346.29
Total Liabilities & Equity
-1,197834.2631.92542.65311.76

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
1,0961,096622.32572.34679.94521.29
Net Cash (Debt)
-1,074-1,074-622.31-572.32-678.87-519.73
Net Cash Growth
------
Net Cash Per Share
-29.06-29.04-17.31-17.86-47.80-40.78
Filing Date Shares Outstanding
36.9136.9436.9833.4814.214.2
Total Common Shares Outstanding
36.9136.9436.9833.4814.214.2
Working Capital
--346.67-549.05-95.89-78.9214.96
Book Value Per Share
-11.27-11.55-6.77-6.01-32.53-24.38
Tangible Book Value
-426.87-426.87-250.25-201.22-462-346.29
Tangible Book Value Per Share
-11.27-11.55-6.77-6.01-32.53-24.38
Land
---1.821.821.82
Buildings
---78.4570.4357.66
Machinery
---425.07392.04304.93
Construction In Progress
-----3.43